The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study-Reference-Cited by-同舟云学术

The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study

Published:2023-10-23 Issue:2 Volume:45 Page:
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Aljuhani Ohoud¹,Al Sulaiman Khalid²³⁴⁵,B Korayem Ghazwa⁶,Alharbi Aisha⁷,Altebainawi Ali F.⁸⁹,Aldkheel Shatha A.⁶,Alotaibi Sarah G.⁶,Vishwakarma Ramesh¹⁰,Alshareef Hanan¹¹,Alsohimi Samiah¹²¹³,AlFaifi Mashael¹⁴,Al Shaya Abdulrahman²³⁴,Alhaidal Haifa A.³,Alsubaie Raghad M.³,Alrashidi Hessah³,Albarqi Khalid J.³,Alangari Dalal T.³,Alanazi Reem M.³,Altaher Noora M.³,Al-Dorzi Hasan M.⁴¹⁵¹⁶

Affiliation:

1. Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia

2. Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia

3. College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

4. King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

5. Saudi Critical Care Pharmacy Research (SCAPE) Platform, Riyadh, Saudi Arabia

6. Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

7. Pharmaceutical Care Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia

8. Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Ministry of Health, Hail, Saudi Arabia

9. Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia

10. Norwich Medical School, University of East Anglia, Norwich, UK

11. Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia

12. Pharmaceutical Care Services, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia

13. Pharmaceutical Care Services, King Abdulaziz University Hospital, Jeddah, Saudi Arabia

14. Pharmaceutical Care Department, King Saud Medical City, Riyadh, Saudi Arabia

15. Intensive Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia

16. College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2023.2268213

Reference46 articles.

1. WHO Coronavirus (COVID-19) Dashboard. 2023. https://covid19.who.int

2. Efficacy of tocilizumab treatment in severely ill COVID-19 patients

3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

4. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

5. The pathogenesis of coronavirus-19 disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Trends in Complications Associated with SARS-CoV-2 Infection;Biomedicines;2023-12-19